`80
`80
`
`160
`160
`160
`
`240
`240
`240
`
`320
`320
`320
`
`400
`400
`400
`
`480
`480
`480
`
`560
`560
`560
`
`640
`640
`640
`
`720
`720
`720
`
`800
`800
`800
`
`880
`880
`880
`
`1. U S_2 0 0 6 _0 2 1 7 3 1 1 _A 1 _3
`2. U S_7 3 7 4 7 5 8 _B2 _1 5
`3. U S_9 2 5 4 3 3 8 _B2 _1
`
`1 23
`
`1 23
`
`12 3
`
`12 3
`
`1 2 3
`
`1 23
`
`12 3
`
`12 3
`
`1 2 3
`
`1 23
`
`1 23
`
`Mylan Exhibit 1094
`Mylan v. Regeneron, IPR2021-00881
`Page 1
`
`Joining Petitioner: Apotex
`
`
`
`AGGTGCATAATGCCAAGACAAAGCCGCGGGAGGAGCAGTACAACAGCACGTACCGTGTGGTCAGCGTCCTCACCGTCCTG
`AGGTGCATAATGCCAAGACAAAGCCGCGGGAGGAGCAGTACAACAGCACGTACCGTGTGGTCAGCGTCCTCACCGTCCTG
`AGGTGCATAATGCCAAGACAAAGCCGCGGGAGGAGCAGTACAACAGCACGTACCGTGTGGTCAGCGTCCTCACCGTCCTG
`
`960
`960
`960
`
`CACCAGGACTGGCTGAATGGCAAGGAGTACAAGTGCAAGGTCTCCAACAAAGCCCTCCCAGCCCCCATCGAGAAAACCAT
`CACCAGGACTGGCTGAATGGCAAGGAGTACAAGTGCAAGGTCTCCAACAAAGCCCTCCCAGCCCCCATCGAGAAAACCAT
`CACCAGGACTGGCTGAATGGCAAGGAGTACAAGTGCAAGGTCTCCAACAAAGCCCTCCCAGCCCCCATCGAGAAAACCAT
`
`CTCCAAAGCCAAAGGGCAGCCCCGAGAACCACAGGTGTACACCCTGCCCCCATCCCGGGATGAGCTGACCAAGAACCAGG
`CTCCAAAGCCAAAGGGCAGCCCCGAGAACCACAGGTGTACACCCTGCCCCCATCCCGGGATGAGCTGACCAAGAACCAGG
`CTCCAAAGCCAAAGGGCAGCCCCGAGAACCACAGGTGTACACCCTGCCCCCATCCCGGGATGAGCTGACCAAGAACCAGG
`
`TCAGCCTGACCTGCCTGGTCAAAGGCTTCTATCCCAGCGACATCGCCGTGGAGTGGGAGAGCAATGGGCAGCCGGAGAAC
`TCAGCCTGACCTGCCTGGTCAAAGGCTTCTATCCCAGCGACATCGCCGTGGAGTGGGAGAGCAATGGGCAGCCGGAGAAC
`TCAGCCTGACCTGCCTGGTCAAAGGCTTCTATCCCAGCGACATCGCCGTGGAGTGGGAGAGCAATGGGCAGCCGGAGAAC
`
`1040
`1040
`1040
`
`1120
`1120
`1120
`
`1200
`1200
`1200
`
`AACTACAAGACCACGCCTCCCETGCTGGACTCCGACGGCTCCTTCTTCCTCTACAGCAAGCTCACCGTGGACAAGAGCAG
`AACTACAAGACCACGCCTCCCGTGCTGGACTCCGACGGCTCCTTCTTCCTCTACAGCAAGCTCACCGTGGACAAGAGCAG
`AACTACAAGACCACGCCTCCCGTGCTGGACTCCGACGGCTCCTTCTTCCTCTACAGCAAGCTCACCGTGGACAAGAGCAG
`
`1280
`1280
`1280
`
`GTGGCAGCAGGGGAACGTCTTCTCATGCTCCGTGATGCATGAGGCTCTGCACAACCACTACACGCAGAAGAGCCTCTCCC
`GTGGCAGCAGGGGAACGTCTTCTCATGCTCCGTGATGCATGAGGCTCTGCACAACCACTACACGCAGAAGAGCCTCTCCC
`GTGGCAGCAGGGGAACGTCTTCTCATGCTCCGTGATGCATGAGGCTCTGCACAACCACTACACGCAGAAGAGCCTCTCCC
`
`1360
`1360
`1360
`
`TGTCTCCGGGTAAATGA 1377
`TGTCTCCGGGTAAATGA 1377
`TGTCTCCGGGTAAATGA 1377
`
`12 3
`
`12 3
`
`1 2 3
`
`1 23
`
`1 23
`
`12 3
`
`1 2 3
`
`Mylan Exhibit 1094
`Mylan v. Regeneron, IPR2021-00881
`Page 2
`Joining Petitioner: Apotex
`
`Mylan Exhibit 1094
`Mylan v. Regeneron, IPR2021-00881
`Page 2
`
`Joining Petitioner: Apotex
`
`